Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

• Conditions: Invasive Aspergillosis; Hematological Diseases

• Registration Number: NCT00838643
• Lead Sponsor: Ospedale Santa Croce-Carle Cuneo

Brief Summary

Evaluation of incidence of invasive aspergillosis in patients who have undergone an allogeneic stem cell transplantation, with particular regard to the role of galactomannan assay and of early TC scan in asymptomatic patients.

Detailed Description

Not available

Study Timeline

• Study Start: 2002-05
• Primary Completion: 2007-06
• Status Verified: 2009-02
• Study First Submitted: 2009-02-05
• Study First Submitted QC: 2009-02-05
• Study First Posted: 2009-02-06
• Last Update Submitted: 2009-02-06
• Last Update Posted: 2009-02-09
• Study Completion: 2009-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 220

Inclusion Criteria

• Age > 16 years
• Allogeneic HSCT for a haematological disease
• Written informed consent to the study

Exclusion Criteria

• Pediatric patients

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of invasive aspergillosis	1 year

Secondary Outcome Measures

Name	Time	Method
Clinical applicability of the EORTC/MSG criteria in a prospective multicenter trial	1 year

Trial Locations

Locations (1)

Azienda Sanitaria Ospedaliera santa Croce e Carle; 🇮🇹 Cuneo, Italy